Emily Kamen, MD
Otolaryngology · Covington, LANPI 1437685393
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medical Device Business Services, Inc. at 59.4% of the total. Reporting peaked in 2022 at $2,918 and has fallen 95.4% since, to $136 in 2025.
Across 30 payments — averaging $143.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$3K
- Intuitive Surgical$1K
- Organogenesis Inc.$223
- Optinose US, Inc.$120
- Johnson & Johnson$80
- GSK$80
- plus $212 from 6 others
What the payments were for
- Travel & lodging$2,13750%
- Food & beverage$1,15727%
- Education$1,00023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 13 | $2,550 |
| Intuitive Surgical | 2 | $1,029 |
| Organogenesis Inc. | 3 | $223 |
| Optinose US, Inc. | 2 | $120 |
| Johnson & Johnson | 1 | $80 |
| GSK | 2 | $80 |
| Stryker | 2 | $71 |
| Acclarent, Inc | 1 | $59 |
| Boston Scientific | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $18 |
| Lifenet Health | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,000
- PuraPly$122
- Xhance$109
How this compares
$4,294 in reported general payments places this provider in the 80th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pilocarpine Hcl | 13 | $498 |
| Pentoxifylline | 14 | $258 |
| Oxycodone Hcl | 26 | $140 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $104 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Covington
- Kevin McLaughlinCovington$186K
- Brad LebertCovington$7K
- Donald GonzalesNew Orleans$351K
- Adil FatakiaMarrero$148K
- Edward McCoulNew Orleans$92K
- Michael YimShreveport$77K
- Maura CosettiShreveport$64K
- Lizabeth ClarkeNew Iberia$40K
- Henry BarhamBaton Rouge$32K
- Cherie-Ann NathanShreveport$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.